Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;92(5):e70017.
doi: 10.1111/aji.70017.

Circ-ADAM9 Knockdown Reduces Insulin Resistance and Placental Injury in Diabetic Mice via MAPK Pathway Inactivation

Ai Zhao  1 , Yawen Yang  1 , Yijun Yang  1 , Zhenjing Chi  1 , Yanlan Sun  1
Affiliations

Circ-ADAM9 Knockdown Reduces Insulin Resistance and Placental Injury in Diabetic Mice via MAPK Pathway Inactivation

Ai Zhao et al. Am J Reprod Immunol. 2024 Nov.

Abstract

Background: Gestational diabetes mellitus (GDM) significantly risks maternal and neonatal health. Circular RNAs (circRNAs) regulate various diseases but their role in GDM is unclear. We investigated the involvement of circ-ADAM9 in GDM.

Methods: We analyzed circ-ADAM9 expression in GDM-related microarray data (GSE182737) and measured its levels in the blood of GDM patients. In a high-fat diet-induced GDM mouse model, we inhibited circ-ADAM9 expression and tracked blood glucose levels, serum insulin, lipid levels, placental apoptosis, and reactive oxygen species (ROS) levels. Pathological changes in pancreatic tissues and fetal outcomes were also examined. Molecular interactions were explored using bioinformatics tools and validated through luciferase assays, real-time quantitative polymerase chain reaction (RT-qPCR), and Western blotting in high glucose (HG)-induced human trophoblast cells (HTR-8/SVneo). We further investigated the involvement of circ-ADAM9/miR-375/FPR2 axis in HG-induced injury in HTR-8/SVneo cells by assessing cell viability, apoptosis, ROS production, and antioxidant levels.

Results: Both GDM patients and GDM-induced mice exhibited a substantial upregulation of circ-ADAM9. Knockdown of circ-ADAM9 lowered blood glucose, alleviated insulin resistance, improved lipid metabolism, decreased placental apoptosis and ROS levels, and reduced pancreatic lesions in GDM mice. Circ-ADAM9 downregulation also improved fetal viability, weight, and crown-rump length. In HG-induced HTR-8/SVneo cells, circ-ADAM9 overexpression and miR-375 downregulation were evident. Overexpression of miR-375 inhibited circ-ADAM9 activity, substantiating their binding interaction. In GDM mice, circ-ADAM9 deficiency restored miR-375 expression. TargetScanHuman predicted and luciferase assays confirmed the miR-375-FPR2 interaction and elevated FPR2 levels in GDM mice were reduced by circ-ADAM9 silencing. In HG-induced HTR-8/SVneo cells, circ-ADAM9 knockdown restored cell viability, suppressed apoptosis and ROS levels, and enhanced antioxidant enzyme levels. These effects were reversed by miR-375 inhibition or FPR2 overexpression, suggesting circ-ADAM9 upregulates FPR2 expression by sponging miR-375 and modulating the MAPK pathway.

Conclusion: This study is the first to demonstrate the expression and function of circ-ADAM9 in the progression of GDM. Circ-ADAM9 downregulation ameliorates insulin resistance and placental injury in GDM by modulating the miR-375/FPR2 axis and inactivating the MAPK pathway, which may offer a novel therapeutic target for the treatment of GDM.

Keywords: FPR2; circ‐ADAM9; diabetes mellitus; insulin resistance; miR‐375.

PubMed Disclaimer

References

    1. E. D. Szmuilowicz, J. L. Josefson, and B. E. Metzger, “Gestational Diabetes Mellitus,” Endocrinology and Metabolism Clinics of North America 48, no. 3 (2019): 479, https://doi.org/10.1016/j.ecl.2019.05.001.
    1. J. H. Moon and H. C. Jang, “Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal‐Offspring Complications,” Diabetes & Metabolism Journal 46, no. 1 (2022): 3, https://doi.org/10.4093/dmj.2021.0335.
    1. W. Ye, C. Luo, J. Huang, C. Li, Z. Liu, and F. Liu, “Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes: Systematic Review and Meta‐Analysis,” BMJ 377 (2022): e067946, https://doi.org/10.1136/bmj‐2021‐067946.
    1. E. U. Alejandro, T. P. Mamerto, G. Chung, et al., “Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes,” International Journal of Molecular Sciences 21, no. 14 (2020), https://doi.org/10.3390/ijms21145003.
    1. Y. X. Li, D. L. Long, J. Liu, et al., “Gestational Diabetes Mellitus in Women Increased the Risk of Neonatal Infection via Inflammation and Autophagy in the Placenta,” Medicine 99, no. 40 (2020): e22152, https://doi.org/10.1097/md.0000000000022152.

MeSH terms